DCTH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DCTH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-04-26), Delcath Systems's current share price is $12.11. Delcath Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $398.14. Delcath Systems's Cyclically Adjusted PS Ratio for today is 0.03.
The historical rank and industry rank for Delcath Systems's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Delcath Systems's highest Cyclically Adjusted PS Ratio was 5348.74. The lowest was 0.01. And the median was 0.02.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Delcath Systems's adjusted revenue per share data for the three months ended in Dec. 2024 was $0.471. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $398.14 for the trailing ten years ended in Dec. 2024.
The historical data trend for Delcath Systems's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
0.03 | 0.01 | 0.01 | 0.01 | 0.03 |
Delcath Systems Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
For the Medical Devices subindustry, Delcath Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Delcath Systems's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Delcath Systems's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 12.11 | / | 398.14 | |
= | 0.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:
For example, Delcath Systems's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2024 (Change) | * | Current CPI (Dec. 2024) |
= | 0.471 | / | 133.1571 | * | 133.1571 | |
= | 0.471 |
Current CPI (Dec. 2024) = 133.1571.
Delcath Systems Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201503 | 0.000 | 99.621 | 0.000 |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.000 | 100.392 | 0.000 |
201512 | 0.000 | 99.792 | 0.000 |
201603 | 0.000 | 100.470 | 0.000 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.000 | 101.861 | 0.000 |
201612 | 0.000 | 101.863 | 0.000 |
201703 | 0.000 | 102.862 | 0.000 |
201706 | 0.000 | 103.349 | 0.000 |
201709 | 342.000 | 104.136 | 437.312 |
201712 | 352.000 | 104.011 | 450.637 |
201803 | 702.000 | 105.290 | 887.803 |
201806 | 858.000 | 106.317 | 1,074.607 |
201809 | 16.157 | 106.507 | 20.200 |
201812 | 68.200 | 105.998 | 85.674 |
201903 | 2.571 | 107.251 | 3.192 |
201906 | 4.039 | 108.070 | 4.977 |
201909 | 3.725 | 108.329 | 4.579 |
201912 | 7.716 | 108.420 | 9.476 |
202003 | 4.027 | 108.902 | 4.924 |
202006 | 0.167 | 108.767 | 0.204 |
202009 | 0.109 | 109.815 | 0.132 |
202012 | 0.085 | 109.897 | 0.103 |
202103 | 0.060 | 111.754 | 0.071 |
202106 | 0.080 | 114.631 | 0.093 |
202109 | 0.069 | 115.734 | 0.079 |
202112 | 0.270 | 117.630 | 0.306 |
202203 | 0.046 | 121.301 | 0.050 |
202206 | 0.097 | 125.017 | 0.103 |
202209 | 0.098 | 125.227 | 0.104 |
202212 | 0.064 | 125.222 | 0.068 |
202303 | 0.051 | 127.348 | 0.053 |
202306 | 0.040 | 128.729 | 0.041 |
202309 | 0.024 | 129.860 | 0.025 |
202312 | 0.023 | 129.419 | 0.024 |
202403 | 0.126 | 131.776 | 0.127 |
202406 | 0.274 | 132.554 | 0.275 |
202409 | 0.346 | 133.029 | 0.346 |
202412 | 0.471 | 133.157 | 0.471 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Delcath Systems (NAS:DCTH) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Delcath Systems's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Gil Aharon | director | 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7 |
Salamon Steven A J | director | 25 ADMIRAL ROAD, TORONTO A6 M5R 2L4 |
Vojo Vukovic | officer: See Remarks | C/O SYNTA PHARMACEUTICALS CORP., 45 HARTWELL AVENUE, LEXINGTON MA 02421 |
Gerard J Michel | director, officer: Chief Executive Officer | 420 CHIPETA WAY, SALT LAKE CITY UT 84108 |
Sandra Pennell | officer: See Remarks | C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139 |
David L. Hoffman | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
John Purpura | officer: EVP, Regulatory Affairs | 600 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10020 |
John Richard Sylvester | director | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Rosalind Advisors, Inc. | director, other: See Remarks | 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7 |
Kevin Muir | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Anthony Dias | officer: Vice President of Finance | C/O SEACHANGE INTERNATIONAL, 50 NAGOG PARK, ACTON MA 01720 |
Johnny John | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Elizabeth Czerepak | director | 201 ROUTE 17 NORTH, RUTHERFORD NJ 07070 |
Christine Padula | officer: See Remarks | C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019 |
Simon Pedder | director | 1001 MAIN STREET, SUITE 600, BUFFALO NY 14203 |
From GuruFocus
By GuruFocus News • 12-30-2024
By GuruFocus News • 01-28-2025
By GuruFocus News • 11-09-2024
By GuruFocus News • 04-14-2025
By GuruFocus News • 01-16-2025
By GuruFocus News • 12-27-2024
By Business Wire • 12-02-2024
By GuruFocus News • 03-07-2025
By Business Wire • 10-25-2024
By Business Wire • 03-24-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.